Silibinin Therapy Improves Cholangiocarcinoma Outcomes by Regulating ERK/Mitochondrial Pathway

Background: Silibinin is widely utilized drug in various cancer treatments, though its application in cholangiocarcinoma has not yet been explored. For the first time, we evaluated the anticancer potential and underlying molecular mechanism of silibinin in treatment of cholangiocarcinoma treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Yang, Chen, Jiaqi, Hu, Weijian, Wang, Lei, Wu, Yulian, Yu, Shi’an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983842/
https://www.ncbi.nlm.nih.gov/pubmed/35401195
http://dx.doi.org/10.3389/fphar.2022.847905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983842/
https://www.ncbi.nlm.nih.gov/pubmed/35401195
http://dx.doi.org/10.3389/fphar.2022.847905

Ejemplares similares